VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,930,000 | -65.6% | 80,000 | -58.0% | 0.76% | -76.4% |
| Q3 2021 | $5,607,000 | -96.0% | 190,261 | -95.4% | 3.21% | -72.8% |
| Q2 2021 | $141,784,000 | +564.5% | 4,172,561 | +535.6% | 11.78% | +335.5% |
| Q1 2021 | $21,337,000 | -70.6% | 656,490 | -67.4% | 2.70% | -63.3% |
| Q4 2020 | $72,470,000 | +16.2% | 2,011,912 | +26.3% | 7.38% | +4.1% |
| Q3 2020 | $62,382,000 | +689.6% | 1,592,996 | +639.7% | 7.08% | +867.9% |
| Q2 2020 | $7,900,000 | +5.0% | 215,367 | -34.1% | 0.73% | -52.7% |
| Q1 2020 | $7,526,000 | +42.4% | 326,659 | +30.4% | 1.55% | +51.7% |
| Q4 2018 | $5,284,000 | +9.5% | 250,509 | -3.8% | 1.02% | +173.5% |
| Q3 2018 | $4,825,000 | -56.0% | 260,509 | -47.0% | 0.37% | -58.3% |
| Q2 2018 | $10,974,000 | +207.6% | 491,869 | +206.9% | 0.90% | +61.6% |
| Q1 2018 | $3,568,000 | – | 160,269 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |